Anti-Snake Venom Administration Guidelines

Initial Assessment and Preparation

The American College of Medical Toxicology recommends ensuring epinephrine (0.01 mg/kg in children up to 0.3 mg; 0.3-0.5 mg in adults) is immediately available for anaphylactic reactions 1
Airway management equipment and ventilatory support capability should be available, especially for neurotoxic envenomation (krait, cobra) 2
Cardiac monitoring equipment should be used to monitor patients 3
Emergency resuscitation medications including antihistamines and corticosteroids should be available 3
Remove all rings and constricting objects from the bitten extremity immediately to prevent tissue damage from progressive swelling 1, 2

The recommended starting dose is 10 vials of polyvalent ASV, which provides adequate neutralization without increasing adverse reaction risk compared to lower doses 1, 2
Administer additional 5-10 vials every 4-6 hours if coagulation parameters remain abnormal 3
Administer additional 5-10 vials every 4-6 hours if new systemic symptoms develop 2

Dilute the ASV in normal saline (0.9% sodium chloride) at a ratio of 1:5 to 1:10 3
Administer the diluted ASV intravenously over 1 hour via slow IV infusion 3
Use a dedicated IV line with appropriate vascular access 3
Start infusion slowly for the first 10-15 minutes while monitoring closely for hypersensitivity reactions 3

Continuously monitor vital signs (blood pressure, heart rate, respiratory rate) every 15 minutes initially, then every 30 minutes 3
Monitor signs of anaphylaxis: urticaria, bronchospasm, hypotension, angioedema 1, 3
Monitor respiratory status, particularly for neurotoxic envenomation 2
Monitor cardiac rhythm via ECG monitoring 3
Monitor progression of local swelling 2

Stop ASV infusion immediately if anaphylaxis occurs 3
Administer epinephrine intramuscularly in the anterolateral thigh (0.01 mg/kg in children up to 0.3 mg; 0.3-0.5 mg in adults) if anaphylaxis occurs 1
Provide airway support and supplemental oxygen if anaphylaxis occurs 2
Administer IV antihistamines and corticosteroids if anaphylaxis occurs 3

Hospital stocking recommendations suggest maintaining 12-18 vials for initial treatment capacity 4, 1

The American Heart Association recommends against using inadequate initial doses, such as 2 vials, as this necessitates multiple dosing rounds without improving outcomes and prolongs the period of inadequate venom neutralization, and also advises against applying tourniquets, ice, suction, or electric shock therapy, as these interventions are ineffective and potentially harmful 5
The American Academy of Allergy, Asthma, and Immunology states that antihistamines and corticosteroids are not substitutes for epinephrine in treating anaphylaxis 6